Inactive Instrument
ARYx Therapeutics, Inc. Stock Other OTC
Stocks
ARYX
US0433871094
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 9.03M 7.82M 7.29M 6.71M 12.67M 859M 12.81M 85.72M 33.64M 430M 33.93M 33.18M 1.42B | P/E 2008 |
-1.76x | P/E 2009 | -2.66x |
|---|---|---|---|---|---|
| Enterprise Value | 11.41M 9.88M 9.21M 8.47M 15.99M 1.08B 16.17M 108M 42.47M 543M 42.84M 41.89M 1.8B | EV / Sales 2008 |
4,019,605x | EV / Sales 2009 | - |
| Free-Float |
100% | Yield 2008 * |
-
| Yield 2009 | - |
| 1 day | +47.06% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +47.06% | +4.62% | - | - | 33 | |
| +4.35% | +16.60% | +58.11% | +95.21% | 62.53B | |
| +2.83% | -3.48% | +24.97% | +67.25% | 52.43B | |
| +0.91% | -0.83% | -17.01% | -13.43% | 23.1B | |
| +0.27% | -3.98% | -11.28% | +350.30% | 21.4B | |
| +3.30% | +10.48% | +32.07% | -4.77% | 21.17B | |
| +0.75% | +1.34% | +32.22% | -25.25% | 17.76B | |
| +9.88% | +23.61% | +222.87% | +385.49% | 15.47B | |
| +4.41% | +6.65% | +22.20% | +643.48% | 14.68B | |
| +1.25% | +2.48% | +51.36% | +179.72% | 14.08B | |
| Average | +7.44% | +4.45% | +46.17% | +186.44% | 26.96B | |
| Weighted average by Cap. | +3.11% | +5.40% | +41.44% | +140.37% |
| 2008 | 2009 | |
|---|---|---|
| Net sales | 19.72 17.08 15.92 14.65 27.65 1.88K 27.96 187.13 73.45 938.4 74.08 72.45 3.11K | - |
| Net income | -31.22M -27.04M -25.2M -23.18M -43.76M -2.97B -44.25M -296M -116M -1.49B -117M -115M -4.92B | -33.17M -28.73M -26.78M -24.63M -46.49M -3.15B -47.01M -315M -124M -1.58B -125M -122M -5.23B |
| Net Debt | -29.9 -25.9 -24.14 -22.21 -41.92 -2.84K -42.39 -283.72 -111.36 -1.42K -112.32 -109.84 -4.71K | 2.37 2.05 1.91 1.76 3.32 225.45 3.36 22.49 8.83 112.8 8.91 8.71 373.6 |
Employees
-
